Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies

Treatment for patients with chronic lymphocytic leukemia (CLL) is becoming more individualized due to the recent introduction of novel molecularly targeted therapies into the therapeutic armamentarium. Genomic and molecular risk factors in CLL patients determine the individual risk for disease progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojima, Kensuke, Burger, Jan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Lymphoreticular Tissue Research 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810251/
https://www.ncbi.nlm.nih.gov/pubmed/32404571
http://dx.doi.org/10.3960/jslrt.20002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810251/
https://www.ncbi.nlm.nih.gov/pubmed/32404571
http://dx.doi.org/10.3960/jslrt.20002

Ejemplares similares